Visit | Screen | Baseline | Follow-up visits | Early termination visit/unscheduled study visit | ||||
---|---|---|---|---|---|---|---|---|
Visit number | 1 | 2 | 3 | 4 | 5 | 6 | 7 | -- |
Day of visit | Up to day −7 | 1 | 2 | 5±2 | 8+1 | 11+7 | 30±7 | Variable |
Informed consent | X | |||||||
Review eligibility criteria | X | X | ||||||
Serum HCG pregnancy test | X | |||||||
Urine pregnancy test | X | |||||||
Demographics | X | |||||||
Height and weight | X | |||||||
Medical history | X | |||||||
Medication history | X | |||||||
Review of systems | X | X | X | X | X | X | X | X |
Treatment assignment | X | |||||||
Administration of study product | X | |||||||
Concomitant medications | X | X | X | X | X | X | X | |
Physical examination | X | |||||||
Symptom-directed physical examination | X | X | X | X | X | X | X | |
Vital signs | X | X | X | X | X | X | X | X |
Spirometry | X | X | X | X | X | X | X | X |
Sputum collection for microbiology and phage pharmocokinetics | X | X | X | X | X | X | X | X |
Clinical chemistry | X | X | X | X | X | X | X | |
Liver function tests | X | X | X | X | X | X | X | X |
Hematology | X | X | X | X | X | X | X | |
Serum for phage pharmacokinetics | X | X | ||||||
Cystic Fibrosis Questionnaire-Revised (stage 2 only) | X | X | ||||||
Cystic Fibrosis Respiratory Symptom Diary (stage 2 only) | X | X | X | X | X | X | X | |
Safety assessment | X | X | X | X | X | X | X | |
Events of special interest | X | X | X | X | X |